Magi 5, from the hexathelid spider Macrothele gigas, is a 29-residue polypeptide containing three disulfide bridges. It binds specifically to receptor site 4 on mammalian voltage-gated sodium channels and competes with scorpion ␤-toxins, such as Css IV from Centruroides suffusus suffusus. As a consequence, Magi 5 shifts the activation voltage of the mammalian rNav1.2a channel to more hyperpolarized voltages, whereas the insect channel, DmNav1, is not affected. To gain insight into toxinchannel interactions, Magi 5 and 23 analogues were synthesized. The three-dimensional structure of Magi 5 in aqueous solution was determined, and its voltage-gated sodium channel-binding surfaces were mapped onto this structure using data from electrophysiological measurements on a series of Ala-substituted analogues. The structure clearly resembles the inhibitor cystine knot structural motif, although the triple-stranded ␤-sheet typically found in that motif is partially distorted in Magi 5. The interactive surface of Magi 5 toward voltage-gated sodium channels resembles in some respects the Janus-faced atracotoxins, with functionally important charged residues on one face of the toxin and hydrophobic residues on the other. Magi 5 also resembles the scorpion ␤-toxin Css IV, which has distinct nonpolar and charged surfaces that are critical for channel binding and has a key Glu involved in voltage sensor trapping. These two distinct classes of toxin, with different amino acid sequences and different structures, may utilize similar groups of residues on their surface to achieve the common end of modifying voltage-gated sodium channel function.
Magi 5, from the hexathelid spider Macrothele gigas, is a 29-residue polypeptide containing three disulfide bridges. It binds specifically to receptor site 4 on mammalian voltage-gated sodium channels and competes with scorpion ␤-toxins, such as Css IV from Centruroides suffusus suffusus. As a consequence, Magi 5 shifts the activation voltage of the mammalian rNav1.2a channel to more hyperpolarized voltages, whereas the insect channel, DmNav1, is not affected. To gain insight into toxinchannel interactions, Magi 5 and 23 analogues were synthesized. The three-dimensional structure of Magi 5 in aqueous solution was determined, and its voltage-gated sodium channel-binding surfaces were mapped onto this structure using data from electrophysiological measurements on a series of Ala-substituted analogues. The structure clearly resembles the inhibitor cystine knot structural motif, although the triple-stranded ␤-sheet typically found in that motif is partially distorted in Magi 5. The interactive surface of Magi 5 toward voltage-gated sodium channels resembles in some respects the Janus-faced atracotoxins, with functionally important charged residues on one face of the toxin and hydrophobic residues on the other. Magi 5 also resembles the scorpion ␤-toxin Css IV, which has distinct nonpolar and charged surfaces that are critical for channel binding and has a key Glu involved in voltage sensor trapping. These two distinct classes of toxin, with different amino acid sequences and different structures, may utilize similar groups of residues on their surface to achieve the common end of modifying voltage-gated sodium channel function.
Voltage-gated sodium channels (VGSC) 3 are responsible for the generation and propagation of electrical signals in excitable cells. A variety of different isoforms of VGSC has been identified (1), with ten mammalian (Na v 1.1-Na v 1.9 and Na x ) and several invertebrate (e.g. Drosophila DmNav1, housefly Vssc1, cockroach Para CSMA , and cockroach BgNa v 1-1) VGSCs cloned to date. The Na v 1.1-Na v 1.9 isoforms all have greater than 50% amino acid sequence identity in the transmembrane and extracellular domains. Most of these VGSCs have been expressed functionally in mammalian cell lines and/or an oocyte expression system and can be studied using electrophysiological techniques (2) . The structural diversity of these channels coincides with variations in physiological and pharmacological properties (3) . At least eight distinct toxin-binding sites have been characterized by radioligand binding studies on vertebrate and insect VGSCs (4, 5) . Among them, binding sites for polypeptide toxins from scorpions, sea anemones, spiders, and cone snails are distributed on the extracellular surface of the VGSC and have played a key role in the study of VGSC topology, function, and pharmacology (1, 6, 7) . Scorpion ␣-toxins bind to receptor site 3, which involves extracellular loops of domains I and IV of the VGSC (8, 9) . This site is also recognized by the sea anemone toxin ATXII and spider ␦-atracotoxins (9 -12), which differ structurally but exert a similar inhibitory effect on VGSC inactivation. Scorpion ␤-toxins bind to receptor site 4, which was shown to involve domain II in mammalian VGSCs (13) (14) (15) .
Mutagenesis studies on scorpion ␤-toxins have identified a number of residues critical for the pharmacological activity toward either insects or mammals (16 -20) . A putative pharmacophore involved in the interaction of scorpion ␤-toxins with receptor site 4 on the VGSC was reported by Cohen et al. (16) to consist of a functional discontinuous surface composed of a number of nonpolar and three charged amino acids clustered around the main ␣-helical motif and the C-tail. In 2005, Cohen et al. (17) reported the successful recombinant expression of the classical scorpion ␤-toxin Css IV from Centruroides suffusus suffusus, fused to a His tag and a thrombin cleavage site. A functionally important surface was described, consisting of: 1) a cluster of residues associated with the ␣-helix, surrounding a putative hot spot (Glu 28 ); 2) a hydrophobic cluster associated mainly with the ␤ 2 and ␤ 3 strands; 3) a single residue (Trp 58 ) in the C-tail, and 4) a negatively charged residue (Glu 15 ) involved in voltage sensor trapping. Recently, it was found that this receptor site 4 in mammals was also recognized by a spider toxin, Magi 5, from the hexathelid spider Macrothele gigas (Iriomote, Japan) that binds specifically to the receptor site 4 in mammals (12) . Magi 5 is also found in the venom of the hexathelid spider Macrothele raveni (Guangxi, China), where it was named raventoxin III (21) . Magi 5 is a 29-residue polypeptide stabilized by three disulfide bridges. It is lethal to mice upon intracranial injection and competes with the scorpion ␤-toxin Css IV with a K i of 1.2 nM. Magi 5 and Css IV bind to the same receptor on the sodium channel from rat brain synaptosomes (12) .
Magi 5 is less than half the size of the scorpion ␤-toxins that act at site 4, making it a valuable tool for defining structurefunction relationships and toxin-channel interactions. We have therefore determined its structure by NMR and characterized its mode of action on rNav1.2a. Moreover, we have identified key elements of the VGSC binding surface of Magi 5 by performing an alanine scan of the toxin and assaying these mutants on rNav1.2a expressed in Xenopus laevis oocytes using the twoelectrode voltage-clamp technique.
EXPERIMENTAL PROCEDURES
Peptide Synthesis-All of the chemicals used in this study were of analytical grade. The C-terminally carboxylated forms (identical to native) of Magi 5, and all of the Magi 5 mutants were chemically synthesized by a solid-phase method using the 0.1-mmol Fmoc (N-(9-fluorenyl)methoxycarbonyl) methodology on an Applied Biosystems 433A peptide synthesizer. Cleavage and deprotection of peptide resins were performed using a chemical mixture composed of 1 g of crystalline phenol, 0.2 g of imidazole, 1 ml of thioanisol, 0.5 ml of 1,2-ethanedithiol in 20 ml of trifluoroacetic acid. The resin was removed by filtration, and the deprotected peptides in solution were precipitated using cold ethyl ether. The precipitated peptide was washed twice with cold ether to remove remaining scavengers and protecting groups. The crude linear synthetic peptides were dissolved in 20% aqueous acetonitrile, and purified by reversed phase HPLC on a semi-preparative C 8 column (5C8MS, 10 ϫ 250 mm; Nacalai Tesque, Japan) to 85-90% homogeneity, to eliminate synthetic byproducts and incorrectly assembled peptides. The six free cysteine residues were allowed to oxidize in air for 24 h at room temperature in 0.5 M aqueous ammonium acetate solution (pH 8.0) containing 1 mM reduced glutathione, 0.1 mM oxidized glutathione. The folded synthetic toxins were purified on the same semi-preparative C 8 reversed phase HPLC column using a 40-min linear gradient from 20 to 60% aqueous acetonitrile, 0.1% trifluoroacetic acid (2 ml/min), followed by cation exchange chromatography as previously described for the native toxins (12) . The structural identity between synthetic and native Magi 5 was verified by capillary zone electrophoresis and cation exchange HPLC coelution experiments, circular dichroism, and MALDI-TOF mass spectrometry (see supplemental materials).
MALDI-TOF Mass Spectrometry-Peptides mixed with ␣-cyano-4-hydroxycinnamic acid matrix (Aldrich) were analyzed on an Applied Biosystems Voyager DE-PRO system in reflector mode. Mass spectra were calibrated with internal peptide standards (LaserBio Labs, France) and analyzed using Data Explorer software.
Circular Dichroism-CD spectra were obtained on a Jasco J-725 spectropolarimeter (Jasco, Japan). The spectra were measured from 260 to 190 nm in 60% trifluoroethanol (pH 7.1) at room temperature, with a 1-mm-pathlength cell. The data were collected at 0.1 nm with a scan rate of 100 nm/min and a time constant of 1 s. The concentration of the toxins determined by amino acid analysis was 30 M.
NMR Spectroscopy and Structure Determination-Magi 5 was dissolved to a final concentration of ϳ2.2 mM in 500 l containing 5% 2 H 2 O and 0.03% sodium azide. The pH was adjusted to 4.5 without buffer present; pH was measured at room temperature with no correction made for isotope effects. Two-dimensional homonuclear TOCSY spectra with a spin lock time of 60 ms, DQF-COSY spectra, and NOESY spectra with mixing times of 70, 200, and 300 ms were recorded on a Bruker DRX-600 spectrometer at 5 and 25°C. A 300-ms NOESY was also acquired at 15°C, and a 300-ms NOESY was acquired at 5°C on a Bruker Avance-800 spectrometer. The water resonance was suppressed using the WATERGATE pulse sequence (22) . Amide exchange rates were monitored by dissolving freeze-dried peptide in 2 H 2 O at pH 3.6 and then recording a series of one-dimensional spectra at 5°C, followed by 60-ms TOCSY spectra. Once the amides had exchanged completely, 300-ms NOESY and E-COSY spectra were acquired. Diffusion measurements were performed using a pulsed field gradient longitudinal eddy-current delay pulse sequence (23, 24) , as implemented by Yao et al. (25) . The spectra were processed using XWINNMR (Version 3.5, Bruker Biospin) and analyzed using XEASY (26) (Version 1.3.13). All of the spectra were collected at 5°C unless otherwise indicated and referenced to an impurity peak at 0.15 ppm or the water resonance.
Magi 5 contains three disulfide bond pairings that were included as restraints in all structure calculations after their correct connectivities were confirmed (see "Results"): 3 J HNH␣ Ͻ 6 Hz, ϭ Ϫ60 Ϯ 30°. If a positive angle could be excluded on the basis of NOE data (27) , angles were restricted to the range Ϫ180 to 0°. A 1 angle for Leu 4 was determined based on analysis of a short mixing NOESY spectrum. No hydrogen bonds were included as structural restraints. The CANDID module of CYANA was used to assign NOE cross-peaks in conjunction with manual assignments. For structure calculations, intensities of NOE cross-peaks were measured in XEASY and calibrated using the CALIBA macro of the program CYANA (version 1.0.6) (28). The final constraint set was scaled by a factor of 1.1 to allow for spin diffusion effects and then used to calculate a family of 100 structures using the standard simulated annealing script supplied with XPLOR-NIH (29) . The 50 lowest energy structures were selected from the 100 calculated initially for energy minimization in a box of water. A family of 20 structures was selected based on energy and stereochemical considerations and was analyzed in PROCHECK-NMR (30) and MOLMOL (31) . Structural figures were prepared using MOLMOL and InsightII (Accelrys, San Diego, CA). The final structures had no experimental distance violations greater than 0.2 Å or dihedral angle violations greater than 5°. The structure of Magi 5 has been deposited in the RCSB Protein Data Bank (32) with accession number 2GX1.
Voltage-gated Sodium Channel Expression-For expression in X. laevis oocytes, the ␤ 1 gene was subcloned into pSP64T (33) . For in vitro transcription, ␤ 1 /pSP64T was linearized with EcoRI. Capped cRNAs were then synthesized from the linearized plasmid using the large scale SP6 mMESSAGE-mMA-CHINE transcription kit (Ambion). The DmNav1/pGH19-13-5 vector (34), tipE/pGH19 vector (35) , and rNav1.2a/ pNa200 vector (36) were linearized with NotI and transcribed with the T7 mMESSAGE-mMACHINE kit (Ambion).
The harvesting of oocytes from anesthetized female X. laevis frogs was as described previously (37) . The oocytes were injected with 50 nl of cRNA at a concentration of 1 ng nl Ϫ1 using a Drummond microinjector (Ambion). The solution used for incubating the oocytes contained: 96 mM NaCl, 2 mM KCl, 1.8 mM CaCl 2 , 2 mM MgCl 2 , and 5 mM HEPES (pH 7.4), supplemented with 50 mg liter Ϫ1 gentamycin sulfate. Electrophysiological Studies-Two-electrode voltage-clamp recordings were performed at room temperature (18 -22°C) using a GeneClamp 500 amplifier (Axon Instruments) controlled by a pClamp data acquisition system (Axon Instruments). Whole cell currents from oocytes were recorded 2-4 days after injection. Voltage and current electrodes were filled with 3 M KCl. Resistances of both electrodes were kept as low as possible (Ͻ0.5 M⍀). Bath solution composition was: 96 mM NaCl, 2 mM KCl, 1.8 mM CaCl 2 , 2 mM MgCl 2 , and 5 mM HEPES (pH 7.4). Using a four-pole low pass Bessel filter, currents were filtered at 1 kHz and sampled at 10 kHz. Leak subtraction was performed using a ϪP/4 protocol. Current traces were evoked in an oocyte expressing the cloned sodium channels according to the following protocols: 1) For current-voltage relationships, from a holding potential of Ϫ90 mV, the cells were depolarized with a three-step protocol. The first and last depolarization of 25-ms duration ranged from Ϫ70 to ϩ40 mV in steps of 10 mV. The second depolarization to a voltage ranging between Ϫ20 and Ϫ10 mV (depending on the VGSC) was used to prime the channels, ensuring maximal binding of the ␤-toxin to the channel. The third segment of 25 ms at Ϫ120 mV ensured recovery from inactivation. Repetition interval was 5 s. The peak currents elicited in the third depolarization were plotted as a function of voltage, resulting in a current-voltage relationship (I-V curve). This data set was used for assessing toxin effect on channel activation. 2) For steady-state inactivation, the oocytes were depolarized with a two-step protocol. From a holding potential of Ϫ90 mV, 500-ms prepulses were generated from Ϫ120 to 0 mV with 5-mV increments, followed by a 50-ms test pulse to Ϫ10 mV. The interval between these sequences was 5 s. The data were fitted with a Boltzmann equation. 3) For recovery from inactivation, the oocytes were depolarized with a two-step protocol. From a holding potential of Ϫ90 mV, a first 50 ms pulse to Ϫ10 mV was given, followed by a second depolarization of 10 ms to Ϫ10 mV, interspersed by variable time intervals (2-82 ms). The data were fitted with a single exponential fit. 4) For the dose-response curve, the oocytes were depolarized from a holding potential of Ϫ90 mV to 100 ms test potentials ranging from Ϫ70 to 0 mV with 10-mV increments at a frequency of 0.2 Hz. The data were fitted with the Hill equation.
RESULTS
Peptide Synthesis and Characterization-Magi 5 was synthesized with its C terminus as the free carboxyl, as observed for the native toxin by mass spectrometry (12) . The identity between the synthetic and native polypeptides was verified by MALDI-TOF mass spectrometry and capillary zone electrophoresis. In a coinjection experiment, native Magi 5 and synthetic Magi 5 coeluted in a single sharp peak (supplemental Fig.  S1 ). Moreover, the circular dichroism spectra of both native Magi 5 and synthetic Magi 5 were also identical (supplemental Fig. S2 ), and both native Magi 5 and synthetic Magi 5 were able to modify with similar effectiveness the sodium currents in expressed rNav1.2a channels (see below). NMR Spectroscopy-The 1 H NMR spectrum of Magi 5 in solution was characterized by broad backbone amide chemical shift dispersion, typical of a structured polypeptide stabilized by disulfide bonds (supplemental Fig. S3 ). Two-dimensional NOESY spectra recorded at 5, 15, and 25°C showed that only one conformation was present in aqueous solution. The single proline at position 28 was predominately in the trans conformation; there was no evidence of cis-trans isomerization. indicated that all amide protons exchanged with solvent within minutes of dissolution of the polypeptide in 2 H 2 O; as a result, no hydrogen bonds were used in structure calculations. Distance constraints were derived from NOESY cross-peak volumes at 5°C and 600 MHz. Constraints were also included from an 800-MHz NOESY spectrum subsequently acquired to resolve overlap and ambiguous NOEs. In the Ramachandran plot, no residues were in the disallowed region as determined by the program PROCHECK-NMR (30), except for Pro and Gly (Table 1) .
Initial structures were calculated using the CANDID module of CYANA. A family of 20 structures determined with no disulfide bonds formed was used to determine the disulfide bonding pattern, because spectral overlap was problematic in the identification of Cys-Cys NOEs. It was clear from these initial structure calculations that Cys 2 and Cys 16 were much closer to one another than to other Cys side chains, so this disulfide was formed in subsequent rounds of structure calculation. To confirm the other two disulfide connectivities, XPLOR-NIH calculations were repeated with two possible combinations of cys- (40, 41) .
Solution Structure of Magi 5-The final experimental constraints and structural statistics for Magi 5 are summarized in Table 1 , and stereo views of the superposition of the family of structures over the backbone heavy atoms are shown in Fig. 2 . These structures were calculated with the disulfide bonds present at each stage of structure calculations. From Table 1 , it could be ascertained that the final family of structures were in good agreement with experimentally derived distance and angle constraints. The family of structures was well defined over most of the polypeptide and has been deposited with the RSBC Protein Data Bank (accession number 2GX1).
The angular order parameters (S) for the , , and 1 angles in the final family of structures are plotted as a function of residue number in supplemental Fig. S5 . Values of S Ͼ 0.8 generally indicate that an angle is well ordered within the family of structures; the backbone and angles were well defined, as measured by this parameter, over the majority of residues, the exceptions being Cys 16 and Gly
17
. and Lys 13 (Ϫ67°/Ϫ32°and Ϫ82°/5°, respectively), indicate that the chain reversal around residues 11-14 is a type I ␤-turn. The chain reversal around residues 15-18 does not fit the description of any of the classical turn types, possibly because of distortions associated with the disulfide links to Cys 15 and Cys 16 . However, it should be noted that there is a dearth of NOEs around this region, and the backbone angu- lar order parameters are less well defined than for the rest of the structure (supplemental Fig. S5 ), perhaps indicating local conformational averaging. Consistent with this, the amide resonance of Cys 16 is quite broad at 5°C, and that of Gly 17 is slightly broader than its neighbors. Whereas Magi 5 fits the consensus sequence expected for ICK fold polypeptides (CX 3-7 CX 3-6 CX 0 -5 CX 1-4 CX 4 -13 C), it lacks the triple-stranded ␤-sheet that is characteristic of these polypeptides (40) . PROCHECK revealed little secondary structure, with only a 3 10 helix between Lys 12 and Glu 14 in 13 of 20 structures, which in fact proves to be a type I ␤-turn (see above).
On average, anti-parallel ␤-sheets have and angles of Ϫ139 and 135°. In Magi 5, the residues expected to be in the ␤-sheet are Ala 20 -Ala 22 and Ile 25 -Cys 26 . When comparing the and angles of Magi 5 to GVIA and PVIIA, it appears the deviations for Magi 5 are greatest compared with GVIA and PVIIA around Ala 22 and Ile 25 as the and angles are both negative for these residues. This is also the case for the angle of Asn21 in PVIIA, where the anti-parallel ␤-sheet is not quite as well defined, as in Magi 5, and is only present in two of 20 structures. Additional evidence that the relevant residues in Magi 5 are involved in a ␤-sheet, albeit a distorted one, include 3 and angles consistent with ␤-sheet structure, but the intervening Lys 8 has a angle around Ϫ40°. There are numerous backbone to backbone NOEs between residues 7-9 and 24 -26.
Ala Scan Analogues-To define the molecular determinants of Magi 5 binding to receptor site 4 of mammalian VGSCs, 23 analogues were synthesized chemically. All of the amino acid residues in Magi 5 except Gly, Cys, and Ala were substituted with Ala. Although Gly could have a functional role, it has a high propensity to form reverse turns in high molecular weight proteins (42) and is an essential component of reverse turns in low molecular weight proteins folded according to the ICK motif (43) . Thus, glycines were excluded from the Ala scan. Because the only Pro residue was positioned at the C-terminal and was not an essential part of the ICK, it was not expected to have a structural role in the molecule, so it was substituted.
The overall assembly and cleavage yield of all 23 synthetic peptides was 76% according to theoretical values of the peptidyl resin and the calculated mass increase for 0.1 mmol peptide to give around 249 mg of crude synthetic peptide. The final yield after chromatographic purification of the linear peptide and refolding was ϳ3%. Analogues W7Y and E14A had the highest and lowest peptide yields, 9% and 0.05%, respectively. The CD spectra of 17 of 23 analogues superimposed well with the CD spectrum of native Magi 5 (Fig. 3A) , indicating that their secondary structures were similar to that of the native Magi 5. Four substitutions (W7A, W18F, W18A, and K12A/W18A) caused an increase in the maximal peak in the range 220 -240 nm (Fig. 3B) . Two substitutions that caused a major change in the CD spectrum were K3A and L4A. Although mass spectrometric analysis of K3A and L4A, before and after folding, indicated that all six cysteine residues were oxidized to disulfide bridges, their CD spectra differed markedly from that of the native Magi 5 (Fig. 3B) , suggesting improper folding or some structural alteration. To examine the effect of Ala substitutions on toxin activity, each analogue was assayed for activity to rNav1.2a expressed in X. laevis oocytes.
Electrophysiological Studies-The two-electrode voltage clamp technique on X. laevis oocytes was used to determine the effects of Magi 5 and 23 Ala-substituted mutants on two different cloned VGSCs, DmNav1/tipE and rNav1.2a/␤ 1 (n Ն 3 for all of the obtained values). From a holding potential of Ϫ90 mV, the cells were depolarized with a four-step protocol (Fig. 4, A-D) .
Magi 5 had no effect on DmNav1/tipE at a concentration up to 5 M, but when the same concentration was applied on rNav1.2a/␤ 1 , a clear effect on the steady-state activation process was visible. Magi 5 also caused a small current inhibition (Ͻ15%) at the voltage of maximal inward current (Ϫ20 mV) when applied on rNav1.2a/␤ 1 . This is a typical phenomenon, also observed with scorpion ␤-toxins (16 -18) . Fig. 4 (B and D) shows the current-voltage relationships in which the currents are normalized for a better view of the activation phase (I/I max ). By normalizing the current-voltage relationships, the activation phase is emphasized, and the small block of the current is eliminated so that comparison of Magi 5 and its mutants is facilitated. Normalized conductance-voltage relationships derived from these data were used to calculate the V1 ⁄2 values. Under the influence of Magi 5, the activation of rNav1.2a/␤ 1 shifted toward more negative potentials (␤-effect) with 10.6 Ϯ 2.1 mV. Magi 5 did not influence the inactivation phase of either studied VGSC.
To investigate the effect of the toxin on steady-state inactivation and on V h (i.e. V1 ⁄ 2 for the steady-state inactivation), a double-pulse protocol was used. As illustrated in (Fig. 4F) . The EC 50 value for the shift in V1 ⁄ 2 was 1.2 Ϯ 0.1 M (Fig. 4G) .
Most mutants shifted the activation process to more negative potentials. The data were analyzed using the Student's t test with a probability of significant difference Ն95%. The ⌬V1 ⁄ 2 values are normalized with Magi 5 (⌬V1 ⁄ 2 ϭ Ϫ10.6 Ϯ 2.1 mV) set to 100 as a reference and displayed in Fig. 5 in a bar diagram. R29A caused a significantly larger hyperpolarizing shift, whereas T5A, F6A, W7A, W7Y, K12A, W18Y, and L23A caused significantly smaller hyperpolarizing shifts. The mutants K8A, N11A, K13A, and K12A/W18Y were not significantly different from wild-type Magi 5. The following mutants have lost their activity on rNav1.2a/␤ 1 : K3A, L4A, F6Y, K10A, E14A, W18F, W18A, N19A, I25A, M27A, and P28A; these mutants are colored red in Fig. 5 and supplemental Table S2 .
DISCUSSION
The solution structure of the 29-residue polypeptide Magi 5, from the hexathelid spider M. gigas, has been determined. Although Magi 5 fits the consensus sequence expected for ICK fold polypeptides (CX 3-7 CX 3-6 CX 0 -5 CX 1-4 CX 4 -13 C), the triple-stranded ␤-sheet that is characteristic of this structural motif (40) is somewhat distorted in this toxin, even though the structure is well defined by the NMR data and has a low backbone root mean square deviation. When the Magi 5 structure is superimposed onto classical ICK structures using the C ␣ positions of the six half-cysteines for alignment, the strong similarity is nonetheless quite clear (supplemental Fig. S6 ). The pairwise root mean square deviations between Magi 5 and the ␤-sheets of -GVIA (RCSB accession number 2CCO) (32, 44) , PVIIA (1AV3) (45) , and Ptu1(1I26) (46) are 0.68, 0.38, and 0.77 Å, respectively. The type II ␤-turn in -GVIA encompassing Ser 3 -Ser 6 cannot be formed in Magi 5 because it has Phe in place of Gly 5 in -GVIA. Instead, Magi 5 contains an inverse ␥-turn centered on Phe 6 . Magi 5 behaves like a classical mammalian-selective ␤-toxin by shifting the steady-state activation voltage of rNav1.2a (but not DmNav1) to more hyperpolarized voltages. In addition, the toxin shifts the steady-state inactivation voltage to more hyperpolarized potentials. However, quantitatively, this effect is less pronounced. The EC 50 value for the shift of the steady-state activation is 1.2 Ϯ 0.1 M. To define the molecular determinants of Magi 5 activity on receptor site 4 of mammalian VGSCs, 23 analogues were synthesized chemically. All of the amino acid residues except Gly, Cys, and Ala were substituted with Ala, and Trp 18 was also replaced by Tyr and Phe. K12A/W18A was also synthesized. The following mutants lost activity on rNav1.2a/ ␤ 1 : K3A, L4A, F6Y, K10A, E14A, W18F, W18A, N19A, I25A, M27A, and P28A (colored red in Fig. 5 ) Two of these, K3A and L4A, showed major changes in their CD spectra (Fig. 3) , implying that their refolding and/or final structures were compromised, and they are therefore excluded from the discussion below. Four (W7A, W18F, W18A, and K12A/W18A) showed changes in their CD spectra in the range 220 -240 nm (Fig. 3B) . These minor changes partly reflect the replacement of Trp by a different side chain, but they do not correlate with loss of activity as W7A, which showed a larger shift in the range 220 -240 nm than W18A, retained some activity, whereas W18A was inactive (Fig. 5) .
As shown in Fig. 6 , the surface of Magi 5 is highly positively charged as a result of its five Lys residues, whereas there is only one negatively charged residue, Glu 14 . By contrast, the opposite face of Magi 5 is not only lacking in charged side chains but is largely nonpolar (Fig. 6A,  right-hand side) . In this respect, Magi 5 resembles the Janus-faced atracotoxins isolated from the Australian funnel web spider Hadro- nyche versuta (47) , which has one highly charged surface and an opposing face essentially devoid of ionizable side chains. More importantly, it also resembles the surface of the scorpion ␤-toxin Css IV (17) , which displays distinct nonpolar and charged surfaces that are critical for VGSC binding, as discussed below.
In Magi 5 it appears that the surface around Lys 13 and Arg 853 in DII for binding of ␤-toxins to channels (6, 14, 48, 49) . Mutagenesis studies on scorpion ␤-toxins themselves have also revealed a number of residues critical for the pharmacological activity toward either insects or mammals (16 -20) . A putative pharmacophore involved in the interaction of scorpion ␤-toxins with receptor site 4 on the VGSC was reported by Cohen et al. (16) . In this study, BjxtrIT from the scorpion Buthotus judaicus was found to have a functional discontinuous surface composed of a number of nonpolar and three charged amino acids clustered around the main ␣-helical motif and the C terminus. In particular, Glu 30 was a putative hot spot. Furthermore, uncoupling of activity from binding was obtained with mutant E15R, acting as an efficient antagonist of Bj-xtrIT. Cohen et al. (17) subsequently identified key residues in the anti-mammalian scorpion ␤-toxin Css IV. A functionally important surface was described, consisting of a cluster of residues associated with the ␣-helix (encompassing the putative hot spot Glu 28 ), a hydrophobic cluster associated mainly with the ␤ 2 and ␤ 3 strands, Trp 58 in the C-terminal tail, and a negatively charged residue (Glu 15 ) involved in voltage sensor trapping. The presence on Magi 5 of distinct polar and nonpolar surfaces that are both essential for activity invites comparison with scorpion ␤-toxins that also act at receptor site 4, such as Css IV (Fig. 6C) . Css IV has two key Glu side chains, the putative hot spot Glu 28 and the voltage sensor trap Glu 15 , whereas Magi 5 contains only one negatively charged side chain, Glu 14 , although it does possess a free C terminus. Glu 14 in Magi 5 is essential for activity and may play a similar role in voltage sensor trapping to that of Glu 15 in Css IV. In this case it is not clear which group on Magi 5 mimics Glu 28 in Css IV, because the only other negatively charged group is the C terminus. However, a C-terminally amidated analogue of Magi 5 showed similar toxicity in vivo and displaced Css IV with the same potency as native Magi 5 with a free C terminus, 4 indicating that the C-terminal carboxylate is not necessary for activity.
The nonpolar surface in Css IV contains essential Tyr and Phe side chains. Magi 5 does not contain Tyr residues, but it does have one Phe, which is essential for activity, although the neighboring Trp 7 is only marginally important. Fig. S7 ). Although Css IV and Magi 5 presumably evolved from different structural ancestors (␣␤-motif versus ICK motif), they target the same site on VGSCs, and similar residues may be involved in their activity. In Magi 5, Glu 14 is 15.3 Å from the C-terminal carboxylate, whereas in Css IV Glu 15 is only 10.8 Å from Glu 28 ; the greater separation of the two carboxylates in Magi 5 is consistent with the observation that the C-terminal carboxylate in Magi 5 can be amidated without affecting activity and is apparently not mimicking Glu 28 in Css IV. Recently the solution structure of BmK-␤IT, an excitatory scorpion ␤-toxin from a Chinese scorpion, was described (50) . This toxin lacks a glutamate residue at the preceding position of the third Cys residue, equivalent to the hot spot Glu 30 in Bj-xtrIT (16, 17) and is the first example of an excitatory scorpion ␤-toxin lacking a Glu at this location (the equivalent residue is Ile 25 ). BmK-␤IT does have a Glu at the equivalent position to Glu 15 in other scorpion ␤-toxins. The lack of a second carboxylate group in Magi 5 that corresponds to Glu 28 in Css IV suggests that Magi 5 may be another example of a site 4 toxin that can function without this hot spot Glu.
In conclusion, Magi 5 represents a valuable new probe of receptor site 4 on mammalian VGSC. This polypeptide adopts an ICK motif structure, quite distinct from the scorpion ␤-toxin fold of Css IV, which is in any case a model rather than an experimentally determined structure. Magi 5 is also less than half the size of the scorpion ␤-toxins, making it a much simpler candidate for defining structure-function relationships and toxin-channel interactions. The high resolution structure described here, in conjunction with the identification of key contributors to the sodium channel binding surface, provide the basis for mapping its interactions with receptor site 4 on mammalian VGSC.
